After reporting that cultured lung cancer cells and tissues possess the capacity to express both catalytically competent and non-competent AChE molecules [8] insights into possible differences in size and abundance of active and inactive AChE subunits were gained by western-blotting of unaffected and cancerous tissue extracts using N19 antibodies. The gene discussed is ACHE; the disease is lung cancer.